Development of the composition and production technology of injection medication for intra-articular introduction based on sodiun hyaluronate

Keywords: sodium hyaluronate; solution for injection; composition development; production technology; stabilization of the solution


Osteoarthrosis is the most widespread disease of musculoskeletal system, which leads to different level of disability in 10–30% of cases. The age of the person is one of the key risk factors for the development of such disease. The most effective resolution is a surgery in which joints are replaced, but this method is very risky and expensive especially for elderly people. That is why development of the composition and research in new technological aspects of biotechnological medication is an actual course in pharmacy.

The aim of research: development of the composition and production technology of injection solution of hyaluronic acid as sodium hyaluronate for the therapy of degenerate inflammatory disease of articulation.

The object of the study is an injection with sodium hyaluronate for intra-articular administration.

Evaluation of the test results when choosing the optimal technology for preparing the injection solution was carried out by the visual method (description, transparency), and by the method of rotational viscometry (viscosity). The suitability of the sterilization regime was determined by physicochemical methods (appearance, transparency, viscosity, pH of the solution) and microbiological method (sterility) according to the requirements of SPhU. The quantitative content of sodium hyaluronate was determined by spectrophotometry (SPhU, 2.2.25) using a carbazole reagent.

The results of the studies  has  been developed the optimal composition  of the drug based on stabilized sodium hyaluronate by the excipient BDE. The resulting solution in its physical-chemical properties are a clear, highly viscous aqueous solution. The developed composition contains (in %): Sodium hyaluronate with a molecular weight of ~ 2 MDA (in terms of 100% substance) – 1.0; BDE – 0.75; sodium chloride – 0.85; phosphate buffer – up to pH from 5.0 to 8.5; water for injection – up to 100%.

The critical parameters of the technological stages for the production of a drug with sodium hyaluronate are determined experimentally. Specific critical parameters are the degassing of a viscous solution, filtration and the conditions of the sterilization mode of the injection solution. It was experimentally established that the optimal parameters for the filtration stage are the use of a Durapore hydrophilic membrane made of polyvinyl difluoride (PVDF), the temperature of the solution is 50 ± 0.5 °C and the use of back pressure mode to reduce the volume wich is filtered per unit time. It was determined that the sterilization mode with saturated steam at a temperature of 121 °C for 8 min is optimal and ensures the quality of the solution in quality criterion of «Sterility».

Samples of the experimental series of injection solution, obtained by the developed technology, comply with the requirements of SPhU for drugs for parenteral use according to physical-chemical and biological quality criteria as appearance, transparency, viscosity, pH of the solution, sterility, assay sodium hyaluronate.


1. Oliinyk M. V., Stadniuk L. A. Suchasna patohenetychna terapiia osteoartrozu, shcho gruntuietsia na dokazakh // Mystetstvo likuvannia. – 2010. – № 1 (67). – S. 27–30.
2. Nosivets D. S. Farmakolohiia khondroprotektoriv (ohliad farmatsevtychnoho rynku Ukrainy) // Visn. problem biolohii i medytsyny. – 2013. – T. 1 (104), Vyp. 4. – S. 57–63.
3. Ruberg Eva-Maria. Development of sustained release formulations for the intra-articular delivery of a therapeutic antibody / Dissertation zur Erlangung des Doktorgrades der Fakultät für Chemie und Pharmazie der Ludwig-Maximilians-Universität München, 2013. – 175 r.
4. Lych I. V., Uhryn A. O., Voloshyna I. M. Hialuronova kyslota: biosyntez ta vykorystannia // Ukr. biofarmats. zh. – 2019. – № 2 (59). – S. 6–13.
5. Savoskyn O. V., Semenova E. F., Rashevskaia E. Yu. y dr. Kharakterystyka razlychnіkh metodov poluchenyia hyaluronovoi kyslotі // Nauchnoe obozrenye. Byol. nauky. – 2017. – № 2. – S. 125–135.
6. Diraçoğlu D., Alptekin K., Teksöz B. et al. Knee vs hip single-joint intra-articular hyaluronic acid injection in patients with both hip and knee osteoarthritis: a pilot study // Clin. Rheumatol. – 2009. – V. 28, N 9. – P. 1021–1024.
7. Nesterchuk M. M., Baula O. P., Hamazin Yu. O. ta in. Osoblyvosti biolohichnykh/biotekhnolohichnykh produktiv ta biosymiliariv. Metod. pekomendatsii. (Skhvaleno na zasidanni Naukovo-ekspertnoi rady Derzhavnoho ekspertnoho tsentru MOZ (protokol № 03 vid 29. 03. 2013 r.). – 37 s.
8. Pramadona and Akbar Adhiutama. The Application of Lean Manufacturing for Operation Improvement: A Case Study of Black Cough Medicine Production in Indonesia // The Asian J. Technol. Management. – 2013. – V. 6, N 1. – R. 56–64. /10.12695/ajtm.2013.6.1.5
9. Derzhavna farmakopeia Ukrainy: v 3t. / DP «Ukrainskyi naukovyi farmakopeinyi tsentr yakosti likarskykh zasobiv». 2-e vyd. – Kharkiv: DP «Ukrainskyi naukovyi farmakopeinyi tsentr yakosti likarskykh zasobiv», 2015. – T. 1. – 1128 s.
10. Sodium Hyaluronate. European Pharmacopoeia 9th, vol. 2 / European Directorate for Qulity of Medicines & Health Care. 9.0th ed. – Strasbourg, 2016. – P. 3583–3585.
11. Zaichenko H. V., Horchakova N. O., Stryha O. A. ta in. Aspekty farmakodynamiky ta klinichnoi farmakolohii hialuronovoi kysloty // Visn. problem biolohii i medytsyny. – 2017. – Vyp. 1 (135). – S. 33–42.
12. Pat. WO 2006021644. Water-soluble crosslinked hyaluronic acid, a metod for the preparation thereof, implant containing said crosslinked hyaluronic acid and the use thereof / Asius Jerome, Asius Benedicte, Riviere Nicolas, Giani Olivia, Robin Jean-Jacques, Vayaboury Koumalen. – Zaiavl. 23. 07. 2004; Opubl. 02. 03. 2006.
How to Cite
Saliy, O. O., Los, O. V., Baula, O. P., & Matsiutsia, K. F. (2019). Development of the composition and production technology of injection medication for intra-articular introduction based on sodiun hyaluronate. Farmatsevtychnyi Zhurnal, (5), 75-85.
Pharmaceutical technology